CaMKII inhibitors and uses thereof

US11325908B2 · kind B2 · utility

Assignee

• THE JOHNS HOPKINS UNIVERSITY · US

Inventors

• Daniel Levy · San Mateo, US
• Howard Schulman · Palo Alto, US
• Bheema R. Paraselli · San Diego, US
• Nangunoori Sampath Kumar · Ghanpur, IN
• Brahmaiah Dabbugoddu · Ghanpur, IN
• Chundru Balasubramanyam · Darsi, IN

Key dates

• Filing date: Aug 24, 2020
• Grant date: May 10, 2022
• Expiry date: Aug 24, 2040

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P35/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention provides compounds useful as inhibitors of Ca2+/calmodulin-dependent protein kinase (CaMKII), compositions thereof, and methods of using the same.